Jin Medical International (ZJYL) Common Equity (2022 - 2025)
Historic Common Equity for Jin Medical International (ZJYL) over the last 4 years, with Q3 2025 value amounting to $29.6 million.
- Jin Medical International's Common Equity rose 357.24% to $29.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.6 million, marking a year-over-year increase of 357.24%. This contributed to the annual value of $29.6 million for FY2025, which is 357.24% up from last year.
- Jin Medical International's Common Equity amounted to $29.6 million in Q3 2025, which was up 357.24% from $27.8 million recorded in Q1 2025.
- In the past 5 years, Jin Medical International's Common Equity registered a high of $29.6 million during Q3 2025, and its lowest value of $15.2 million during Q3 2022.
- For the 4-year period, Jin Medical International's Common Equity averaged around $25.0 million, with its median value being $26.2 million (2024).
- In the last 5 years, Jin Medical International's Common Equity soared by 5738.77% in 2023 and then soared by 357.24% in 2025.
- Quarter analysis of 4 years shows Jin Medical International's Common Equity stood at $15.2 million in 2022, then soared by 57.39% to $24.0 million in 2023, then grew by 19.07% to $28.6 million in 2024, then rose by 3.57% to $29.6 million in 2025.
- Its Common Equity was $29.6 million in Q3 2025, compared to $27.8 million in Q1 2025 and $28.6 million in Q3 2024.